MoonLake Immunotherapeutics (MLTX) Notes Payables (2020 - 2022)

MoonLake Immunotherapeutics' Notes Payables history runs 3 years deep, the most recent figure standing at $150000.0 for Q1 2022.

• In Q1 2022, Notes Payables changed N/A year-over-year to $150000.0; the TTM figure through Mar 2022 stood at $150000.0 (changed N/A YoY), while the FY2021 annual figure was $15.0 million, up 25734.01% from the prior year.
• Notes Payables was $150000.0 for Q1 2022 at MoonLake Immunotherapeutics, down from $15.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $15.0 million in Q4 2021 to a low of $58063.0 in Q4 2020.
• Historically, Notes Payables has averaged $5.1 million across 3 years, with a median of $150000.0 in 2022.
• Biggest YoY gain for Notes Payables was 25734.01% in 2021; the steepest drop was 25734.01% in 2021.
• A 3-year view of Notes Payables shows it stood at $58063.0 in 2020, then soared by 25734.01% to $15.0 million in 2021, then slumped by 99.0% to $150000.0 in 2022.
• The last three Notes Payables figures came in at $150000.0 (Q1 2022), $15.0 million (Q4 2021), and $58063.0 (Q4 2020), per Business Quant data.